The tumour suppressor FOXO3 is a key regulator of mantle cell lymphoma proliferation and survival

British Journal of Haematology

Volumn 156, Issue 3, 2012, Pages 334-345

  Obrador Hevia, Antònia ^a   Serra Sitjar, Margalida ^a   Rodríguez, José ^a,c   Villalonga, Priam ^a,b   de Mattos, Silvia Fernández ^a,b  

^a Institut Universitari d'Investigació en Ciències de La Salut IUNICS   (Spain)

^b UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^c HOSPITAL SEVERO OCHOA   (Spain)

Author keywords

Apoptosis; FOXO; Mantle cell lymphoma; PI3K; Proliferation

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 7; DOXORUBICIN; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR; PSAMMAPLYSENE A; RAPAMYCIN; TRANSCRIPTION FACTOR FKHRL1; TRICIRIBINE; UNCLASSIFIED DRUG;

AKT GENE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL NUCLEUS; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; FOXO3 GENE; GENE; GENE ACTIVITY; GENE EXPRESSION; GENE FUNCTION; GENE INACTIVATION; GENE LOCATION; HUMAN; HUMAN CELL; INHIBITION KINETICS; LYMPHOMA CELL; MANTLE CELL LYMPHOMA; PI3K GENE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TUMOR SUPPRESSOR GENE;

ACTIVE TRANSPORT, CELL NUCLEUS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; DOXORUBICIN; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; LYMPHOMA, MANTLE-CELL; NEOPLASM PROTEINS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-AKT; TRANSCRIPTION, GENETIC; TYROSINE;

EID: 84855782005     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08951.x     Document Type: Article

References (52)

1. Berry, E., Hardt, J.L., Clardy, J., Lurain, J.R. & Kim, J.J. (2009) Induction of apoptosis in endometrial cancer cells by psammaplysene A involves FOXO1. Gynecologic Oncology, 112, 331-336.
2. Birkenkamp, K.U. & Coffer, P.J. (2003) Regulation of cell survival and proliferation by the FOXO (Forkhead box, class O) subfamily of Forkhead transcription factors. Biochemical Society Transactions, 31, 292-297.
3. Bodrug, S.E., Warner, B.J., Bath, M.L., Lindeman, G.J., Harris, A.W. & Adams, J.M. (1994) Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO Journal, 13, 2124-2130.
4. Borkhardt, A., Repp, R., Haas, O.A., Leis, T., Harbott, J., Kreuder, J., Hammermann, J., Henn, T. & Lampert, F. (1997) Cloning and characterization of AFX, the gene that fuses to MLL in acute leukemias with a t(X;11)(q13;q23). Oncogene, 14, 195-202.
5. Bosch, F., Jares, P., Campo, E., Lopez-Guillermo, A., Piris, M.A., Villamor, N., Tassies, D., Jaffe, E.S., Montserrat, E., Rozman, C. & Cardesa, A. (1994) PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. Blood, 84, 2726-2732.
6. Bouchard, C., Lee, S., Paulus-Hock, V., Loddenkemper, C., Eilers, M. & Schmitt, C.A. (2007) FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of Arf. Genes and Development, 21, 2775-2787.
7. Brunet, A., Bonni, A., Zigmond, M.J., Lin, M.Z., Juo, P., Hu, L.S., Anderson, M.J., Arden, K.C., Blenis, J. & Greenberg, M.E. (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell, 96, 857-868.
8. Camacho, E., Hernandez, L., Hernandez, S., Tort, F., Bellosillo, B., Bea, S., Bosch, F., Montserrat, E., Cardesa, A., Fernandez, P.L. & Campo, E. (2002) ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances. Blood, 99, 238-244.
9. Cerchietti, L.C., Ghetu, A.F., Zhu, X., Da Silva, G.F., Zhong, S., Matthews, M., Bunting, K.L., Polo, J.M., Fares, C., Arrowsmith, C.H., Yang, S.N., Garcia, M., Coop, A., Mackerell, Jr, A.D., Prive, G.G. & Melnick, A. (2010) A small-molecule inhibitor of BCL6 kills DLBCL cells in vitro and in vivo. Cancer Cell, 17, 400-411.
10. Coffer, P.J. & Burgering, B.M. (2004) Forkhead-box transcription factors and their role in the immune system. Nature Reviews Immunology, 4, 889-899.
11. Dal Col, J., Zancai, P., Terrin, L., Guidoboni, M., Ponzoni, M., Pavan, A., Spina, M., Bergamin, S., Rizzo, S., Tirelli, U., De Rossi, A., Doglioni, C. & Dolcetti, R. (2008) Distinct functional significance of Akt and mTOR constitutive activation in mantle cell lymphoma. Blood, 111, 5142-5151.
12. Fernández de Mattos, S., Essafi, A., Soeiro, I., Pietersen, A.M., Birkenkamp, K.U., Edwards, C.S., Martino, A., Nelson, B.H., Francis, J.M., Jones, M.C., Brosens, J.J., Coffer, P.J. & Lam, E.W. (2004) FoxO3a and BCR-ABL regulate cyclin D2 transcription through a STAT5/BCL6-dependent mechanism. Molecular and Cellular Biology, 24, 10058-10071.
13. Fernández de Mattos, S., Villalonga, P., Clardy, J. & Lam, E.W. (2008) FOXO3a mediates the cytotoxic effects of cisplatin in colon cancer cells. Molecular Cancer Therapeutics, 7, 3237-3246.
14. Furuyama, T., Nakazawa, T., Nakano, I. & Mori, N. (2000) Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues. Biochemical Journal, 349, 629-634.
15. Galili, N., Davis, R.J., Fredericks, W.J., Mukhopadhyay, S., Rauscher, 3rd, F.J., Emanuel, B.S., Rovera, G. & Barr, F.G. (1993) Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nature Genetics, 5, 230-235.
16. Ghobrial, I.M., McCormick, D.J., Kaufmann, S.H., Leontovich, A.A., Loegering, D.A., Dai, N.T., Krajnik, K.L., Stenson, M.J., Melhem, M.F., Novak, A.J., Ansell, S.M. & Witzig, T.E. (2005) Proteomic analysis of mantle-cell lymphoma by protein microarray. Blood, 105, 3722-3730.
17. Gronbaek, K., Nedergaard, T., Andersen, M.K., thor Straten, P., Guldberg, P., Moller, P., Zeuthen, J., Ebbe Hansen, N., Hou-Jensen, K. & Ralfkiaer, E. (1998) Concurrent disruption of cell cycle associated genes in mantle cell lymphoma: a genotypic and phenotypic study of cyclin D1, p16, p15, p53 and pRb. Leukemia, 12, 1266-1271.
18. Gu, T.L., Tothova, Z., Scheijen, B., Griffin, J.D., Gilliland, D.G. & Sternberg, D.W. (2004) NPM-ALK fusion kinase of anaplastic large-cell lymphoma regulates survival and proliferative signaling through modulation of FOXO3a. Blood, 103, 4622-4629.
19. Habashy, H.O., Rakha, E.A., Aleskandarany, M., Ahmed, M.A., Green, A.R., Ellis, I.O. & Powe, D.G. (2011) FOXO3a nuclear localisation is associated with good prognosis in luminal-like breast cancer. Breast Cancer Research and Treatment, 129, 11-21.
20. Harris, N.L., Jaffe, E.S., Diebold, J., Flandrin, G., Muller-Hermelink, H.K., Vardiman, J., Lister, T.A. & Bloomfield, C.D. (1999) World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. Journal of Clinical Oncology, 17, 3835-3849.
21. Hillion, J., Le Coniat, M., Jonveaux, P., Berger, R. & Bernard, O.A. (1997) AF6q21, a novel partner of the MLL gene in t(6;11)(q21;q23), defines a forkhead transcriptional factor subfamily. Blood, 90, 3714-3719.
22. Hipp, S., Ringshausen, I., Oelsner, M., Bogner, C., Peschel, C. & Decker, T. (2005) Inhibition of the mammalian target of rapamycin and the induction of cell cycle arrest in mantle cell lymphoma cells. Haematologica, 90, 1433-1434.
23. Hoekstra, A.V., Sefton, E.C., Berry, E., Lu, Z., Hardt, J., Marsh, E., Yin, P., Clardy, J., Chakravarti, D., Bulun, S. & Kim, J.J. (2009) Progestins activate the AKT pathway in leiomyoma cells and promote survival. Journal of Clinical Endocrinology and Metabolism, 94, 1768-1774.
24. Jeon, H.J., Kim, C.W., Yoshino, T. & Akagi, T. (1998) Establishment and characterization of a mantle cell lymphoma cell line. British Journal of Haematology, 102, 1323-1326.
25. Kau, T.R., Schroeder, F., Ramaswamy, S., Wojciechowski, C.L., Zhao, J.J., Roberts, T.M., Clardy, J., Sellers, W.R. & Silver, P.A. (2003) A chemical genetic screen identifies inhibitors of regulated nuclear export of a Forkhead transcription factor in PTEN-deficient tumor cells. Cancer Cell, 4, 463-476.
26. Kops, G.J. & Burgering, B.M. (1999) Forkhead transcription factors: new insights into protein kinase B (c- akt) signaling. Journal of Molecular Medicine, 77, 656-665.
27. Kops, G.J., de Ruiter, N.D., De Vries-Smits, A.M., Powell, D.R., Bos, J.L. & Burgering, B.M. (1999) Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature, 398, 630-634.
28. Kornblau, S.M., Singh, N., Qiu, Y., Chen, W., Zhang, N. & Coombes, K.R. (2010) Highly phosphorylated FOXO3A is an adverse prognostic factor in acute myeloid leukemia. Clinical Cancer Research, 16, 1865-1874.
29. Lam, E.W., Francis, R.E. & Petkovic, M. (2006) FOXO transcription factors: key regulators of cell fate. Biochemical Society Transactions, 34, 722-726.
30. Lin, L., Hron, J.D. & Peng, S.L. (2004) Regulation of NF-kappaB, Th activation, and autoinflammation by the forkhead transcription factor Foxo3a. Immunity, 21, 203-213.
31. Melo, J.V., Brito-Babapulle, V., Foroni, L., Robinson, D.S., Luzzatto, L. & Catovsky, D. (1986) Two new cell lines from B-prolymphocytic leukaemia: characterization by morphology, immunological markers, karyotype and Ig gene rearrangement. International Journal of Cancer, 38, 531-538.
32. Moller, C., Alfredsson, J., Engstrom, M., Wootz, H., Xiang, Z., Lennartsson, J., Jonsson, J.I. & Nilsson, G. (2005) Stem cell factor promotes mast cell survival via inactivation of FOXO3a-mediated transcriptional induction and MEK-regulated phosphorylation of the proapoptotic protein Bim. Blood, 106, 1330-1336.
33. Obrador-Hevia, A., Fernández de Mattos, S., Villalonga, P. & Rodríguez, J. (2009) Molecular biology of mantle cell lymphoma: from profiling studies to new therapeutic strategies. Blood Reviews, 23, 205-216.
34. Okkenhaug, K. & Vanhaesebroeck, B. (2003) PI3K in lymphocyte development, differentiation and activation. Nature Reviews Immunology, 3, 317-330.
35. Paik, J.H., Kollipara, R., Chu, G., Ji, H., Xiao, Y., Ding, Z., Miao, L., Tothova, Z., Horner, J.W., Carrasco, D.R., Jiang, S., Gilliland, D.G., Chin, L., Wong, W.H., Castrillon, D.H. & DePinho, R.A. (2007) FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell, 128, 309-323.
36. Peponi, E., Drakos, E., Reyes, G., Leventaki, V., Rassidakis, G.Z. & Medeiros, L.J. (2006) Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma. American Journal of Pathology, 169, 2171-2180.
37. Pinyol, M., Cobo, F., Bea, S., Jares, P., Nayach, I., Fernandez, P.L., Montserrat, E., Cardesa, A. & Campo, E. (1998) p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas. Blood, 91, 2977-2984.
38. Psyrri, A., Papageorgiou, S., Liakata, E., Scorilas, A., Rontogianni, D., Kontos, C.K., Argyriou, P., Pectasides, D., Harhalakis, N., Pappa, V., Kolialexi, A., Economopoulou, C., Kontsioti, F., Maratou, E., Dimitriadis, G., Economopoulou, P. & Economopoulos, T. (2009) Phosphatidylinositol 3′-kinase catalytic subunit alpha gene amplification contributes to the pathogenesis of mantle cell lymphoma. Clinical Cancer Research, 15, 5724-5732.
39. Rimokh, R., Berger, F., Bastard, C., Klein, B., French, M., Archimbaud, E., Rouault, J.P., Santa Lucia, B., Duret, L., Vuillaume, M., Coiffier, B., Bryon, P.A. & Magaud, J.P. (1994) Rearrangement of CCND1 (BCL1/PRAD1) 3′ untranslated region in mantle-cell lymphomas and t(11q13)-associated leukemias. Blood, 83, 3689-3696.
40. Rizzatti, E.G., Falcao, R.P., Panepucci, R.A., Proto-Siqueira, R., Anselmo-Lima, W.T., Okamoto, O.K. & Zago, M.A. (2005) Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3K-AKT, WNT and TGFbeta signalling pathways. British Journal of Haematology, 130, 516-526.
41. Rudelius, M., Pittaluga, S., Nishizuka, S., Pham, T.H., Fend, F., Jaffe, E.S., Quintanilla-Martinez, L. & Raffeld, M. (2006) Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma. Blood, 108, 1668-1676.
42. Rudolph, C., Steinemann, D., Von Neuhoff, N., Gadzicki, D., Ripperger, T., Drexler, H.G., Mrasek, K., Liehr, T., Claussen, U., Emura, M., Schrock, E. & Schlegelberger, B. (2004) Molecular cytogenetic characterization of the mantle cell lymphoma cell line GRANTA-519. Cancer Genetics and Cytogenetics, 153, 144-150.
43. Rummel, M.J., de Vos, S., Hoelzer, D., Koeffler, H.P. & Hofmann, W.K. (2004) Altered apoptosis pathways in mantle cell lymphoma. Leukaemia & Lymphoma, 45, 49-54.
44. Sarbassov, D.D., Ali, S.M., Sengupta, S., Sheen, J.H., Hsu, P.P., Bagley, A.F., Markhard, A.L. & Sabatini, D.M. (2006) Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Molecular Cell, 22, 159-168.
45. Schroeder, F.C., Kau, T.R., Silver, P.A. & Clardy, J. (2005) The psammaplysenes, specific inhibitors of FOXO1a nuclear export. Journal of Natural Products, 68, 574-576.
46. Stahl, M., Dijkers, P.F., Kops, G.J., Lens, S.M., Coffer, P.J., Burgering, B.M. & Medema, R.H. (2002) The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2. Journal of Immunology, 168, 5024-5031.
47. Sunters, A., Fernández de Mattos, S., Stahl, M., Brosens, J.J., Zoumpoulidou, G., Saunders, C.A., Coffer, P.J., Medema, R.H., Coombes, R.C. & Lam, E.W. (2003) FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines. Journal of Bioliogical Chemistry, 278, 49795-49805.
48. Tang, E.D., Nunez, G., Barr, F.G. & Guan, K.L. (1999) Negative regulation of the forkhead transcription factor FKHR by Akt. Journal of Biological Chemistry, 274, 16741-16746.
49. Tothova, Z., Kollipara, R., Huntly, B.J., Lee, B.H., Castrillon, D.H., Cullen, D.E., McDowell, E.P., Lazo-Kallanian, S., Williams, I.R., Sears, C., Armstrong, S.A., Passegue, E., DePinho, R.A. & Gilliland, D.G. (2007) FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell, 128, 325-339.
50. Tucker, C.A., Bebb, G., Klasa, R.J., Chhanabhai, M., Lestou, V., Horsman, D.E., Gascoyne, R.D., Wiestner, A., Masin, D., Bally, M. & Williams, M.E. (2006) Four human t(11;14)(q13;q32)-containing cell lines having classic and variant features of Mantle Cell Lymphoma. Leukemia Research, 30, 449-457.
51. Yusuf, I., Zhu, X., Kharas, M.G., Chen, J. & Fruman, D.A. (2004) Optimal B-cell proliferation requires phosphoinositide 3-kinase-dependent inactivation of FOXO transcription factors. Blood, 104, 784-787.
52. Zhang, J., Grindley, J.C., Yin, T., Jayasinghe, S., He, X.C., Ross, J.T., Haug, J.S., Rupp, D., Porter-Westpfahl, K.S., Wiedemann, L.M., Wu, H. & Li, L. (2006) PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention. Nature, 441, 518-522.